On this day in 1969, NASA formally announced the prime crew selected to carry out the Apollo 11 mission, a decision that would soon mark one of the most defining moments in human history.

Scheduled to launch in early 2026, NASA's Artemis 2 is part of the bold 21st-century vision for returning astronauts to the ...

A local technology museum is inviting you to join the wise men this weekend and learn more about how local innovations have ...

The 26-foot-tall (8-meter-tall) cargo lander is expected to embark on its first flight during the first quarter of 2026, ...

Meanwhile, shares of the company are available in the grey market. According to market observers, shares of Apollo Techno Industries Ltd are available at a premium of ₹10 in the grey market today.

That's one small step for a man. One very expensive leap for the United States. Okay, sure, some would argue focusing on the total cost of the Apollo program defeats the purpose. Stepping onto the ...

Fewer homes are being built than in previous generations on Long Island, where real estate prices continue to soar. According to nextLI, builders sought permits for 1,818 privately-owned homes in 2024 ...

Apollo Global Management Inc.’s third-quarter earnings surpassed Wall Street estimates as the buyout giant edged closer to reaching $1 trillion of assets. Fee-related earnings jumped 23% from a year ...

Apollo 7, crewed by Walter Schirra Jr., Donn Eisele, and Walter Cunningham, represented the first manned American spaceflight 21 months after the Apollo 1 fatal accident. Launching on October 11, 1968 ...

While you probably already know about the Apollo 11 moon landing, you may be surprised to learn that NASA's Apollo Program ran from 1962 to 1972 and included 14 total missions, six of which were lunar ...

Private equity giant Apollo Global Management is reportedly weighing a sale of AOL after receiving unsolicited bids that could value the onetime internet pioneer at around $1.5 billion. Talks are in ...

Apollo Therapeutics’ $15 million bet on Avalo’s anti-IL-18 monoclonal antibody appears to have paid off after the candidate aced a phase 2 trial in atopic dermatitis (AD). The phase 2a study involved ...